MBI Group announced on Friday that it has completed a project to construct and renovate patient care spaces at The Mount Sinai Hospital's Guggenheim Pavilion, located at 1190 Fifth Avenue on Manhattan's Upper East Side.
The company added that it was selected under a competitive bid process .
Under the four-month project, MBI was responsible for the renovation of patient spaces in the haematology, oncology and bone marrow transplant unit. The renovations of patient rooms, nursing stations, restrooms and corridors included interior demolition, millwork, drywall, ceiling work, tiling, terrazzo, flooring, painting, toilet installation, wall protection, plumbing and HVAC, as well as electrical work.
Founded in 1852, The Mount Sinai Hospital is one of the oldest and largest teaching hospitals in the US. The integrated health care system provides exceptional medical care to local and global communities. It is internationally acclaimed for its excellence in research, patient care, and education across a range of specialties.
Established in 1987, MBI Group is a full-service construction firm providing interior fit-outs and core and shell construction for corporate, educational, healthcare, hospitality, institutional, mixed-use and retail facilities.
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Frontage expands early phase clinical research capabilities across US and China
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
InSysBio agrees new collaborative project with BeOne Medicines
Physiomics secures new modelling contract with Numab Therapeutics
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Avacta secures FDA clearance for second pre|CISION oncology programme
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis